
Exagen XGN
$ 7.24
2.99%
Country |
|
IPO year |
2019 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
21.6 M |
Market Cap[1] |
$ 156 M |
EBITDA (LTM) |
$ -12 M |
P/E (LTM) |
-8.150538 |
P/S (LTM) |
2.454547 |
EPS (LTM) |
-0.93 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | ||
|
Anixa Biosciences
ANIX
|
$ 2.8 | 1.45 % | $ 90.9 K | Nasdaq Capital Market | ||
|
Biodesix
BDSX
|
$ 27.53 | 2.1 % | $ 208 M | Nasdaq Global Market | ||
|
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | ||
|
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | ||
|
Syneos Health
SYNH
|
- | - | $ 4.46 B | Nasdaq Global Select Market,SPB | ||
|
Meridian Bioscience
VIVO
|
- | - | $ 1.49 B | Nasdaq Global Select Market | ||
|
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | ||
|
Renalytix AI plc
RNLX
|
- | 5.66 % | $ 22.7 M | Nasdaq Global Market | ||
|
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | ||
|
Psychemedics Corporation
PMD
|
- | -1.84 % | $ 15.3 M | Nasdaq Global Select Market | ||
|
Quotient Limited
QTNT
|
- | -11.32 % | $ 1.1 M | Nasdaq Global Select Market | ||
|
T2 Biosystems
TTOO
|
- | -39.35 % | $ 313 K | Nasdaq Global Select Market | ||
|
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | ||
|
Biomerica
BMRA
|
$ 2.39 | 6.7 % | $ 6.97 M | Nasdaq Capital Market | ||
|
BioNano Genomics
BNGO
|
$ 1.34 | 9.77 % | $ 7.3 M | Nasdaq Capital Market,SPB | ||
|
Burning Rock Biotech Limited
BNR
|
$ 11.62 | 5.68 % | $ 123 M | Nasdaq Global Market | ||
|
Bioventus
BVS
|
$ 13.17 | 1.46 % | $ 877 M | Nasdaq Global Select Market | ||
|
CareDx, Inc
CDNA
|
$ 52.6 | 4.65 % | $ 2.8 B | Nasdaq Global Market,SPB | ||
|
Celcuity
CELC
|
$ 83.67 | 0.26 % | $ 3.91 B | Nasdaq Global Select Market | ||
|
Co-Diagnostics
CODX
|
$ 1.13 | 0.45 % | $ 1.5 M | Nasdaq Capital Market | ||
|
Charles River Laboratories International
CRL
|
$ 271.3 | 0.06 % | $ 13.4 B | NYSE,SPB | ||
|
Castle Biosciences
CSTL
|
$ 33.4 | 3.29 % | $ 968 M | Nasdaq Global Market,SPB | ||
|
Quest Diagnostics Incorporated
DGX
|
$ 239.15 | 1.8 % | $ 26.5 B | NYSE,SPB | ||
|
Danaher Corporation
DHR
|
$ 202.97 | 1.4 % | $ 145 B | NYSE,SPB | ||
|
DarioHealth Corp.
DRIO
|
$ 7.07 | 2.02 % | $ 28.2 M | Nasdaq Capital Market | ||
|
Brainsway Ltd.
BWAY
|
$ 13.69 | 0.14 % | $ 465 M | Nasdaq Global Select Market | ||
|
DexCom
DXCM
|
$ 84.44 | 1.7 % | $ 32.9 B | Nasdaq Global Select Market,SPB | ||
|
Fulgent Genetics
FLGT
|
$ 20.59 | 0.68 % | $ 634 M | Nasdaq Global Market | ||
|
Guardant Health
GH
|
$ 166.13 | 5.56 % | $ 20.8 B | Nasdaq Global Select Market,SPB | ||
|
ICON Public Limited Company
ICLR
|
$ 169.06 | 0.02 % | $ 13.3 B | Nasdaq Global Select Market,SPB | ||
|
IDEXX Laboratories
IDXX
|
$ 510.37 | 1.12 % | $ 41 B | Nasdaq Global Select Market,SPB | ||
|
Illumina
ILMN
|
$ 208.49 | 0.99 % | $ 32.3 B | Nasdaq Global Select Market,SPB | ||
|
IQVIA Holdings
IQV
|
$ 264.85 | 1.18 % | $ 45.5 B | NYSE,SPB | ||
|
Laboratory Corporation of America Holdings
LH
|
$ 314.91 | 1.06 % | $ 26.2 B | NYSE,SPB | ||
|
Lantheus Holdings
LNTH
|
$ 100.34 | 0.08 % | $ 6.77 B | Nasdaq Global Select Market,SPB | ||
|
Medpace Holdings
MEDP
|
$ 592.41 | 0.83 % | $ 17.1 B | Nasdaq Global Select Market,SPB | ||
|
Mettler-Toledo International
MTD
|
$ 1 285.35 | 1.01 % | $ 26.5 B | NYSE,SPB | ||
|
Myriad Genetics
MYGN
|
$ 3.78 | 10.38 % | $ 350 M | Nasdaq Global Select Market,SPB | ||
|
ENDRA Life Sciences
NDRA
|
$ 5.68 | 0.98 % | $ 4.47 M | Nasdaq Global Select Market | ||
|
NeoGenomics
NEO
|
$ 18.43 | 6.44 % | $ 2.36 B | Nasdaq Global Select Market,SPB | ||
|
Neogen Corporation
NEOG
|
$ 11.89 | 0.93 % | $ 2.59 B | Nasdaq Global Select Market,SPB | ||
|
National Research Corporation
NRC
|
$ 22.2 | 5.11 % | $ 497 M | Nasdaq Global Select Market | ||
|
Natera
NTRA
|
$ 340.8 | 3.61 % | $ 46.6 B | Nasdaq Global Select Market,SPB | ||
|
OPKO Health
OPK
|
$ 1.55 | 0.38 % | $ 1.16 B | Nasdaq Global Select Market | ||
|
Pacific Biosciences of California
PACB
|
$ 1.36 | 4.23 % | $ 408 M | Nasdaq Global Select Market,SPB | ||
|
Koninklijke Philips N.V.
PHG
|
$ 25.13 | 2.13 % | $ 23.8 B | NYSE | ||
|
Personalis
PSNL
|
$ 16.34 | 0.8 % | $ 1.46 B | Nasdaq Global Select Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.